ReSkript for Researchers

ReSkript's AI drafts your IIS protocol, ICF, IB, manuscript, or abstract to 90% submission-ready — in two to three hours. Referenced, structured, and ready for your review.

The real bottleneck

"You need at least a three-hour allocation of undistracted, uninterrupted attention to write on the protocol."

You can't write a protocol in 15 minutes between patients. You need the time and the time is the hardest thing to find.
Clinical duties always win. The study idea is ready, but the document waits, and the timeline slips.
Every investigator-initiated study is a little different, so you rebuild the same structural sections study after study.
Manuscripts and abstracts at the end carry the same weight: finding uninterrupted time to write is the constraint.

Scientist wearing a white lab coat, blue gloves, and safety glasses holding a petri dish with blue bacterial colonies, with a microscope in the foreground.

How it works

From a concept in your head toa working draft the same afternoon.

Tell ReSkript about your study

Select the document type and enter your study details — design, indication, endpoints, and thedrug or intervention.

Get a near-complete draft in 2–3 hrs

The AI drafts every section background,rationale, eligibility, endpoints, statistics referenced to current standards.

Review, revise, and own it

Everything opens in Word. You apply your clinicaljudgment, adjust anything study-specific.

Two scientists wearing safety glasses and lab coats working closely together in a laboratory, with scientific equipment visible around them.

What you can generate

Whatever kind of study you run, ReSkript drafts for it.

From a single case report to an adaptive Phase III — protocols, ICFs, IBs,manuscripts, abstracts, and final study reports, tailored to your study type andto FDA or EMA context.

Observational

> Case, case-control & case series
> Cohort (pro / retrospective)
> Cross-sectional
> Population studies

Interventional — drug

> Phase I, II, III
> Phase I/II, II/III
> Adaptive designs, all phases
> FDA & EMA variants

Interventional — device

> Phase I
> Phase II
> Phase III — class I
> Phase III — class II & III

Specialised

> Behavioral
> Bioequivalence
> Therapeutic equivalence
> Bioavailability

Beyond the protocol

> Informed Consent Forms (ICF)
> Investigator's Brochures (IB)
> Manuscripts & publications
> Congress abstracts

End of study

> Final study reports
> Drafted from results
> Structured to standard
> Ready for review

30+ study types · FDA & EMA context · always an editable Word file

A scientist or researcher writing notes on a clipboard in a lab surrounded by beakers and test tubes containing blue liquid.

Trust & accountability

You supervise it. You sign off. It carries your name.

ReSkript accelerates the drafting — it never takes the decision out of your hands. Responsibility for scientific accuracy and compliance stays exactly where it should: with you.

Referenced to ICH / GCP

Drafts are structured against current standards, so you startaligned instead of retrofitting.

Citations you can check

Every referenced claim links to its source — no vague orinvented citations.

Human oversight, by design

You review, revise, and approve. The investigator staysaccountable for the final work.

Disclosure-ready

AI involvement is transparent and easy to document, in line withinstitutional and journal policies.